What if the next breakthrough in mental health didn’t start in a lab — but in nature?

In this episode of Research Renaissance, host Deborah Westphal speaks with Dr. Jacob Hooker, neuroscientist, entrepreneur, and CEO of Sensorium Therapeutics. Dr. Hooker shares how his journey from textile chemistry to molecular imaging led him to build a biotech company focused on nature-inspired treatments for anxiety and other neurological conditions.

With nearly 20% of the U.S. population diagnosed with an anxiety disorder, the need for better treatments is urgent. Dr. Hooker explains why current psychiatric care often relies on trial-and-error prescribing — and how brain imaging, biomarkers, and computational tools may help match patients to the right treatment faster.

This conversation explores the intersection of neuroscience, genetics, psychedelics, stigma, and precision medicine — and why solving even one patient’s journey can create ripple effects for millions.

🔑 Key Takeaways

• Why 85% of brain medicines originate from observations in nature
• The science behind anxiety — and why it’s more than “just feelings”
• How EEG and imaging biomarkers could reduce trial-and-error prescribing
• The resurgence of psychedelic research — and what it’s teaching us
• Why unpredictability in modern life may be driving anxiety rates
• The founder journey from academia to biotech entrepreneurship

⏱️ Episode Timestamps
00:00 – Welcome to Research Renaissance
01:00 – From textile chemistry to neuroscience
03:00 – Why anxiety became Sensorium’s first focus
05:00 – Nature as the origin of psychiatric medicines
10:00 – Psychedelics, drug development, and new mechanisms
13:00 – Social anxiety disorder and stigma
21:00 – Brain imaging and biomarker-guided treatment
27:00 – Why stopping medication can restart the cycle
29:00 – Is modern life increasing anxiety?
33:00 – Personal journey: growing up with mental illness
42:00 – Defining impact in mental health

👤 Guest

Dr. Jacob Hooker
Neuroscientist, entrepreneur, and CEO of Sensorium Therapeutics
Founder of Ether in Mind (Substack)

🔬 About Sensorium Therapeutics

Sensorium Therapeutics develops nature-inspired treatments for anxiety and related neurological conditions. Their approach integrates computational chemistry, molecular imaging, and biomarker strategies to personalize psychiatric treatment.

💬 Join the Conversation

If this episode expanded your understanding of mental health science:

• Follow Research Renaissance
• Share this episode with a colleague or friend
• Leave a review on Apple Podcasts or Spotify
• Visit the Karen Toffler Charitable Trust to explore more conversations

To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.

Technical Podcast Support by Jon Keur at Wayfare Recording Co.

What if depression and anxiety are not just disorders of the brain, but conditions shaped by the entire body?

In this episode of Research Renaissance, host Deborah Westphal speaks with Dr. Scott Russo, Director of the Brain Body Research Institute at Mount Sinai, about a major shift underway in mental health science. His work challenges the long-standing brain-only model of psychiatric illness and explores how inflammation, immune signaling, and organ systems interact with the brain to shape mood, resilience, and disease risk.

From gut health to traumatic injury, this conversation reveals why mental health research is moving toward an integrative “systems biology” approach that could redefine treatment in the next decade.

Key Takeaways

• Mental illnesses often coexist with medical conditions, suggesting they are whole-body disorders rather than isolated brain diseases.
• Chronic inflammation may be a shared biological driver across conditions ranging from depression to cardiovascular disease.
• Signals from peripheral organs can influence emotional states, meaning some emotions may originate in the body before being processed by the brain.
• Environmental exposures, infections, and life experiences may account for the majority of mental health risk, with genetics contributing a smaller portion.
• Emerging therapies may target immune pathways or body-brain signaling rather than neurotransmitters alone.
• Collaboration across disciplines is essential to advancing mental health research, yet institutional silos still limit innovation.

About the Guest

Dr. Scott Russo is Director of the Brain Body Research Institute at the Icahn School of Medicine at Mount Sinai. His work focuses on understanding how immune, metabolic, and neural systems interact to influence psychiatric disorders and resilience.

Resources & Mentions

• Brain-Body Research Institute at Mount Sinai
• Research on inflammation and psychiatric disease
• Advances in vagus nerve stimulation therapies

If you enjoyed this episode:

• Follow Research Renaissance for more conversations shaping the future of health science.
  
  
  
• Share this episode with a colleague exploring neuroscience, psychiatry, or integrative medicine.
  
  
  

Leave a review to help others discover the show.

To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.

Technical Podcast Support by Jon Keur at Wayfare Recording Co.

Modern medicine is not shaped by science alone. It is shaped by ethics, trust, and the difficult decisions made when technology moves faster than society can understand it.

In this episode of Research Renaissance, legendary bioethicist Dr. Art Caplan reflects on a career that helped build the field of bioethics from the ground up. From surviving polio as a child to shaping national policies on organ transplantation, informed consent, and end-of-life care, Caplan offers a deeply personal and historically grounded perspective on how ethical thinking became essential to modern healthcare.

The conversation explores the lingering distrust born from COVID-19, the ethical blind spots of artificial intelligence, the environmental cost of data infrastructure, and why communication between science and the public may be the most urgent challenge ahead.

This episode is both a history lesson and a call to action. Ethics is not abstract philosophy. It is practical problem-solving for real people, real patients, and real consequences.

Key Takeaways

• Bioethics emerged to solve real clinical dilemmas, not theoretical debates.
• Policies such as informed consent, brain-death standards, and organ allocation were shaped by early bioethics work.
• Public trust in medicine declined significantly after COVID-19 due to shifting scientific guidance and poor communication.
• AI introduces ethical risks beyond autonomy and bias, including environmental strain, privacy vulnerability, and unclear liability.
• The U.S. healthcare system’s structure, not just its technology, drives many ethical failures.
• Ethics must move from academic journals into communities through direct engagement and public dialogue.
  

Guest Spotlight

Art Caplan, PhD
One of the founders of modern bioethics, Dr. Caplan has advised governments, medical institutions, and research bodies on issues ranging from organ transplantation policy to emerging AI ethics. His work bridges philosophy, clinical medicine, and public engagement.

Topics Discussed

• Origins of bioethics as a discipline
• Human subject protections and informed consent
• End-of-life decision frameworks and hospice care
• Vaccine hesitancy and post-pandemic mistrust
• Ethical governance of artificial intelligence in healthcare
• Environmental implications of digital infrastructure
• Structural inequities in U.S. healthcare delivery
• The role of communication in rebuilding scientific trust

If you found this conversation valuable:

• Follow Research Renaissance for more conversations at the intersection of science, policy, and human health.
• Share this episode with colleagues working in healthcare, research, or ethics.
• Leave a review to help more listeners engage with these critical discussions.

To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.

Technical Podcast Support by Jon Keur at Wayfare Recording Co.

Parkinson’s disease begins decades before symptoms appear — and by the time tremors start, brain changes have already been unfolding for years.
In this episode of Research Renaissance, host Deborah Westphal speaks with Dr.

Zachary Sorrentino, neurosurgeon, physician-scientist, and 2025 Toffler Scholar at the University of Florida. Dr. Sorrentino explains how misfolded proteins like alpha-synuclein spread through the brain, how deep brain stimulation helps restore movement, and why preventing dementia in Parkinson’s patients may be the next major frontier.

Drawing from both the operating room and the research lab, Dr. Sorrentino shares how his team analyzes proteins directly from surgical tools used in living patients — offering unprecedented insight into disease progression.
This is a powerful conversation about aging, brain vulnerability, precision therapies, and the human side of neurosurgery.

🔑 Key Takeaways
Why age is the strongest risk factor for Parkinson’s disease
How misfolded alpha-synuclein spreads through the brain
What deep brain stimulation actually does
Why Parkinson’s symptoms begin decades before diagnosis
The connection between Parkinson’s and dementia
How targeted drug delivery through brain blood vessels may shape the future
The emotional realities of neurosurgery and patient care

⏱️ Episode Timestamps
00:00 – Introduction to Parkinson’s and Lewy body disorders
02:30 – The MD-PhD pathway and physician-scientist model
08:30 – What deep brain stimulation does
10:00 – The 20-year silent phase of Parkinson’s
12:00 – Studying proteins from surgical tools
16:00 – Why dementia is the greatest fear
24:00 – How misfolded proteins spread
27:00 – The role of aging in neurodegeneration
31:00 – Detecting pathological proteins in living patients
42:00 – Stroke breakthroughs in the last decade
48:00 – Targeted therapies and personalized brain medicine
54:00 – The human side of neurosurgery

👤 Guest
Dr. Zachary Sorrentino
Neurosurgeon and Physician-Scientist
University of Florida
2025 Toffler Scholar

🧠 Topics Covered

• Parkinson’s disease
• Alpha-synuclein and Lewy bodies
• Protein misfolding and neurodegeneration
• Deep brain stimulation (DBS)
• Targeted gene therapy delivery
• Stroke intervention advances
• Aging and brain health

💬 Join the Conversation
If this episode deepened your understanding of Parkinson’s disease:
Follow Research Renaissance
Share this episode with someone in neuroscience or medicine
Leave a review on Apple Podcasts or Spotify
Subscribe for more conversations shaping the future of human health

To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.

Technical Podcast Support by Jon Keur at Wayfare Recording Co.

For decades, Parkinson’s disease has been viewed primarily as a disorder of dopamine-producing brain cells.

But what if that’s only part of the story?

In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Rebecca Wallings, Assistant Professor of Neurology at Indiana University’s Stark Neuroscience Research Institute, to explore a groundbreaking shift in how we understand Parkinson’s.

Dr. Wallings explains why the immune system — and specifically immune cell exhaustion — may be a key driver of disease progression. She challenges the prevailing “too much inflammation” narrative and introduces the provocative idea that Parkinson’s may involve a burned-out, aging immune system rather than simply an overactive one.

This conversation dives into:

• The role of lysosomes in immune and brain cells
  
  
• Why most preclinical Parkinson’s models may overlook aging
  
  
• Gut-first vs. brain-first Parkinson’s subtypes
  
  
• Immune exhaustion and its connection to aging
  
  
• Lifestyle factors that may influence disease progression
  
  
• Why future therapies may need to be personalized
  
  

Key Takeaways

• Parkinson’s may be a whole-body condition, not just a brain disease.
  
  
• Aging dramatically alters immune function — yet many models study “young” immune systems.
  
  
• Immune exhaustion may prevent proper resolution of inflammation.
  
  
• Non-motor symptoms (constipation, sleep disorders, loss of smell) can appear decades before diagnosis.
  
  
• Stratifying patients by biological immune age could transform treatment strategies.

About Our Guest

Dr. Rebecca Wallings
Assistant Professor of Neurology
Indiana University – Stark Neuroscience Research Institute

Dr. Wallings studies the role of immune cell exhaustion and aging in Parkinson’s disease, challenging traditional pathology-focused models and exploring translational therapeutic strategies.

Resources Mentioned

• Stark Neuroscience Research Institute
• Research on immune checkpoint inhibitors
• Studies on REM Behavior Disorder and Parkinson’s risk
• Research into biological aging clocks

Enjoyed This Episode?

If this conversation expanded your thinking:

• Subscribe to Research Renaissance
• Leave a review on Apple Podcasts or Spotify
• Share this episode with a colleague or friend
• Follow us for more conversations at the frontier of health science

To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.

Technical Podcast Support by Jon Keur at Wayfare Recording Co.

In this episode of Research Renaissance, host Deborah Westphal sits down with neuroscientist Micaelly Alves, PhD candidate at Temple University and a 2025 Toffler Scholar supported by the Karen Toffler Charitable Trust.

Micaelly shares her personal journey into neuroscience, inspired by watching her grandmother’s battle with Alzheimer’s disease, and dives into groundbreaking research on microRNAs, tiny molecules that may hold the key to earlier diagnosis and more personalized treatment for Alzheimer’s and cerebral amyloid angiopathy.

The conversation explores how brain research is evolving, why personalized medicine matters, and how emerging technologies like RNA sequencing and bioinformatics are accelerating discovery.

⭐ Key Takeaways

• How microRNAs regulate brain pathways linked to Alzheimer’s disease
• Why Alzheimer’s may begin developing 20 years before symptoms appear
• The role of blood-brain barrier health in cognitive decline
• How extracellular vesicles may enable early blood-based diagnostics
• Why personalized medicine is the future of neurological care
• The challenges and promise of big data and AI in neuroscience
• How philanthropy supports early-career researchers and innovation

🔬 Resources & Mentions

• Temple University Neuroscience Program
• MicroRNA research in Alzheimer’s disease
• Cerebral amyloid angiopathy (CAA)
• RNA sequencing and transcriptomics

👉 Enjoying Research Renaissance?

If you found this episode helpful:

✅ Subscribe on Apple Podcasts or Spotify
✅ Share this episode with a friend or colleague
✅ Leave a review to help more listeners discover the show

To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.

Technical Podcast Support by Jon Keur at Wayfare Recording Co.

How does neuroscience shape state policy? And what happens when scientists step inside government?

In this episode of Research Renaissance, Deborah Westphal sits down with Dr. Julianne McCall, CEO of the California Council on Science and Technology (CCST), to explore how scientific thinking informs public policy in one of the world’s largest economies.

From spinal cord injury research in Germany to advising California’s Governor during COVID-19, Dr. McCall shares how scientists can help governments navigate AI, climate, energy, and public health in a rapidly accelerating world.
This conversation reveals what it really takes to translate research into action.

Key Takeaways
Why scientific training is uniquely suited for policymaking
How California integrates nonpartisan science advisors into government
The role of “the Third House” in shaping legislation
Why AI policy must evolve every six months
How fellowship programs are training the next generation of science policy leaders
Why community and trust are central to effective governance

About the Guest
Dr. Julianne McCall
CEO, California Council on Science and Technology
Neuroscientist turned science policy leader with experience spanning academia, international research, state government, and public engagement.

Resources & Links
California Council on Science and Technology: https://ccst.us
CCST Science & Technology Policy Fellowship
Calls for Experts (AI, Quantum, Emerging Technologies)
Science & Technology Week at the California State Capitol

Listen & Connect
If you found this episode valuable:
Follow Research Renaissance
Share this episode with a colleague in science or public policy
Leave a review on Apple Podcasts or Spotify
Science doesn’t move society alone. It needs translation.

To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.

Technical Podcast Support by Jon Keur at Wayfare Recording Co.

In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Şiyar Bahadır, neurosurgeon and Elmezzi Scholar at the Feinstein Institute for Medical Research, to explore the cutting edge of neuroscience, bioelectronic medicine, and the powerful role of the vagus nerve in regulating nearly every organ system in the body.

Dr. Bahadır shares his journey from the operating room to advanced research, explains how mapping the brain and nervous system is revolutionizing patient outcomes, and dives into groundbreaking therapies using electrical stimulation to treat inflammatory diseases like rheumatoid arthritis.

The conversation also uncovers how the brain reorganizes itself after trauma, the future of precision neurosurgery, and why the vagus nerve may hold the key to an entirely new form of medicine.

Key Takeaways

• The vagus nerve acts as a central communication highway between the brain and major organs
• How bioelectronic medicine uses electrical stimulation instead of drugs to treat disease
• Real-world success of vagus nerve stimulation for rheumatoid arthritis (now FDA approved)
• Why mapping neural networks improves surgical precision and recovery
• The brain’s ability to reorganize itself (plasticity) after injury or surgery
• How AI and advanced imaging are shaping the future of neurosurgery

Guest Information

Dr. Şiyar Bahadır
Neurosurgeon | Elmezzi Scholar | Feinstein Institute for Medical Research

📧 Email: sbahadir@northwell.edu
🔗 LinkedIn: Şiyar Bahadır

Resources Mentioned

• The Great Nerve by Dr. Kevin Tracy (on the vagus nerve and bioelectronic medicine)

If you enjoyed this episode, please:

✅ Subscribe to Research Renaissance
✅ Leave a review on Apple Podcasts or Spotify
✅ Share this episode with colleagues interested in neuroscience and medical innovation

Your support helps us bring more groundbreaking research conversations to you!

To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.

Technical Podcast Support by Jon Keur at Wayfare Recording Co.